The presence of histamine H2-receptors in mammalian salivary gland had been inferred from classical pharmacological experiments (1-3). In the submandibular gland of the dog, these receptors were suggested to be located in the glandular vascular bed (1) . whereas in the submandibular gland of the guinea pig (2) and parotid gland of the dog (3), the H2-receptors had been shown to mediate the increase in tissue cyclic AMP. However, the nature of these experiments did not permit direct identification and characterization of the adenyl cyclase-linked receptor in the salivary gland. Two other considerations also prompted us to investigate the H2-receptors of the salivary gland. First, 3H-cimetidine and other tritiated imidazole ligands had been shown to bind to an imidazole recognition site rather than the pharmacological H2 receptor in tissues which have been shown by classical pharmacological experiments to possess H2-receptors (4, 5) . The status of the imidazole recognition site vis-a-vis the H2 receptor in the salivary gland is currently unknown. Second, we wished to verify a personal premise that specific H2-receptors exist in the salivary gland because the salivary glands are transversed by the stomach acupuncture meridian which also courses over the heart (6). H2-receptors are present in both the stomach and the heart.
The submandibular glands and the in traorbital lacrimal gland (control gland) of adult Wistar-Kyoto rats were surgically removed, minced and homogenized in 25 volumes of 50 mM Tris-HCI buffer, pH 7.4, using a teflon pestle-fitted Potter-Elvejhem homogenizer.
The homogenate was filtered through gauze cloth and centrifuged at 32,000 x g for 20 min at 4'C. The pellet was resuspended with the same volume of buffer and recentrifuged.
The last procedure was repeated twice, after which the pellet was finally resuspended in 5 volumes of buffer.
For the assay, 0.2 ml portions of the resuspended pellet were incubated at 24°C with either 5 nM of 3H-cimetidine (Am ersham, 26 curies per nmole) plus various increasing concentrations (10-8 M to 10-2 M) of non-radioactive drugs for displace ment experiments or increasing concen tration (4 nM to 250 nM) of 3H-cimetidine in the absence and presence of non-radioactive cimetidine for saturation experiments in a total volume of 1 ml buffer in 7-ml poly propylene centrifuge tubes. In the saturation experiment, the relative concentration of the non-radioactive cimetidine to that of 3H cimetidine was maintained at a ratio of 200:1, After 30 min incubation, the mixture was centrifuged at 40,000xg for 30 min. The supernatanf was then poured off, and two 5-ml portions of icecold distilled water were used to rinse the tube and the pellet. The radioactivity was measured in 6 ml of scintillation cocktail using a Beckman LS 7500 liquid scintillation counter. The scin tillation cocktail consisted of 10 g 2,5 diphenyloxazole, 2 g 1,4-bis[2-(5-pheny loxazolyl)] benzene, 16 g naphthalene, 770 ml dioxane, 770 ml toluene and 460 ml methanol. Counting efficiency was 22%. Figure 1 shows that 3H-cimetidine binds to a single receptor in the salivary gland membrane and that the binding is saturable and reversible. No such binding occurs with the lacrimal gland preparation. Initial experi ments showed that this binding was linearly related to tissue concentration up to 0.08 g of wet tissue per ml. Binding at 24°C was greater than at 0°C, and binding equilibrium occurs fairly rapidly at around 10 min. The dissociation constant (Kd) for cimetidine as determined by Scatchard analysis was 1 23+1 5 nM, and the total number of binding sites (Bmg,) was 83+8 pmoles/g wet gland. The latter value corresponds to the range of maximum binding values for other receptors in peripheral tissues (7, 8) .
From the displacement experiments, the IC50 for cimetidine, metiamide, 4-methyl histamine, histamine, 2-(2-pyridyl)ethylamine and ranitidine were calculated using the logit transformation (9) . These values were then used for the calculations of the inhibition constants (Kd) for the six drugs with the use of the equation K;=IC50/1 +([3H-cimetidine] /Kd) (10). From the results (see Fig. 1 and Table 1 ), we are of the opinion that this immaculate binding of 3H-cimetidine to the salivary gland membrane, which has all the "fine dressing" of a ligand-receptor combination,
is not the specific 3H-cimetidine-H2-receptor complex but the well-characterized 3H cimetidine-1midazole-recognition-receptor complex found in the membrane preparation of the brain, gastric mucosae and atrium. In the displacement experiments, only cimetidine and metiamide displace 3H-cimetidine at a concentration range commonly observed for ligands that compete for the same receptor. The non-imidazole H2-receptor antagonist ranitidine displaces 3H-cimetidine from the binding in the millimolar range. There is also a remarkable similarity between our data (in terms of the order and magnitude of IC50 and K; for the six drugs) and those reported for the imidazole recognizing receptor in other tissues (see Table 1 ). It is also of interest to note that the displacement of 3H cimetidine by H2-receptor agonists occurs in the micromolar range irrespective of whether these agonists are imidazole or non-imidazole derivatives. This observation is also seen in the results of others (4, 5) and those of Gajtkowski and co-workers who have shown specific H2-receptor ligand binding in the guinea pig cerebral cortex with 3H-tiotidine, but was not able to obtain the same results using the brain of a different animal or the right atrium and gastric mucosae of the same animal (11). 
